Impact of the COVID-19 Pandemic on Central Precocious Puberty: a Retrospective Cohort Study from Turkey

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

192 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-01

Study Completion Date

2023-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective: This study investigates the clinical and demographic characteristics of girls diagnosed with central precocious puberty (CPP) in the pre-pandemic and pandemic periods to assess potential changes during the COVID-19 pandemic.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Animation Supported COVID-19 Education

NCT05633485

COVID-19 Pandemic

COMPLETED NA

Wear Your Mask, Wash Your Hands, Don't Get COVID-19

NCT05572840

Coronavirus Child, Only

COMPLETED NA

Effect of Fertility Health Education Program on Fertility Health Knowledge and Healthy Life Awareness

NCT06639269

Youth Education Fertility

COMPLETED NA

The Effect of Social Media-Based Education on the Knowledge and Attitudes of Women of Childbearing Age in the Preconception Period and on Healthy Lifestyle Behaviors

NCT07082140

Social Media Based Education

NOT_YET_RECRUITING NA

Long-Term Impact of COVID-19 Restrictions on Physical Activity and Social Interactions in Young Adults

NCT06135623

COVID-19 Social Interaction Physical Inactivity

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Methods: A retrospective cohort study was conducted on patients admitted to the Pediatric Endocrinology Departments of two centers in Turkey. Girls treated with GnRH analogs between March 2018 and 2022 were categorized into two groups: the pre-pandemic group (2018-2020) and the pandemic group (2020-2022). Clinical, anthropometric, and hormonal data were analyzed. Patients with organic lesions, genetic conditions, or medications affecting puberty were excluded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID19- Infection with SARS-CoV-2 Virus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

prepandemic and pandemic precocious puberty groups were compared

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Girls: Tanner stage ≥2 before age 8 peak LH \> on gnrh analog test, basal Lh \>0,3

Patients with organic lesions (e.g., hypothalamo-pituitary tumors), congenital malformations, oncological diseases, neurosurgical or genetic disorders, or medications affecting puberty were excluded from the study

Maximum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No